On July 16, Intuitive Surgical rose 3.16% in regular trading, trading at $403.9 USD/share, with turnover of $225 million. The rally was driven by a broad-based rebound across the medical device sector combined with pre-earnings positioning ahead of the company's Q2 report scheduled for release after market close.

The Health Care Equipment sector saw significant capital inflows, with Abbott Laboratories surging 13.48%, Stryker up 5.83%, Boston Scientific up 5.31%, and Medtronic up 4.59%. The sector bounce follows a sharp selloff earlier in the week that pushed ISRG to 52-week lows amid multiple analyst price-target reductions. BMO Capital Markets has highlighted that Intuitive Surgical currently trades at approximately a 31% discount to its three-year historical P/E multiple despite possessing the strongest fundamentals among peers, attributing sector weakness to capital rotation toward AI rather than deteriorating fundamentals.

The company's Q1 results showed revenue growth of 23% year-over-year to $2.77 billion with adjusted EPS of $2.50, both exceeding consensus estimates. Full-year procedure volume growth guidance remains at 13.5% to 15.5%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)